Effect of methotrexate administration on status of some essential trace elements and antioxidant enzymes in pregnant rats in late gestation

References

• Winter ME. Methotrexate. In: Basal clinical pharmacokinetics, 2nd ed. Winter ME, editors. Spokane, WA: Applied Therapeutics, 1988. pp 199–217.
   Google Scholar
• Crom WR, Evans WE. Methotrexate. In: Applied pharmacokinetics: principles of therapeutic drug monitoring, 3rd ed. Evans WE, Schentag JJ, Jusko WJ, editors. Spokane, WA: Applied Therapeutics, 1992. pp 29–43.
   Google Scholar
• Orlando L, Cardillo A, Rocca A, Balduzzi A, Ghisini R, Perozzotti G, Goldhirsch A, D'alessandro C, Cinieri S, Preda L, et al Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancer. Anticancer Drugs 2006;17:961–967.
   PubMed Web of Science ®Google Scholar
• Pels H, Schlegel U. Primary central nervous system lymphoma. Curr Treat Options Neurol 2006;8:346–357.
   PubMedGoogle Scholar
• Franklin JL, Finlay J. Leukemias and lymphomas: treatment and prophylaxis of the central nervous system. Curr Treat Options Neurol 2006;8:335–345.
   PubMedGoogle Scholar
• Nakayama N, Koizumi W, Tanabe S, Sasaki T, Saigenji K. A phase II study of combined chemotherapy with methotrexate, 5-fluorouracil and low-dose cisplatin(MFP) for histologically diffuse-type advanced and recurrent gastric cancer (KDOG 9501). Gastric Cancer 2006;9:185–191.
   PubMedGoogle Scholar
• Shigehara K, Kitagawa Y, Nakashima T, Shimamura M. Squamous cell carcinoma of the baldder: a patient treated successfully with a new combined chemotherapy regimen, intraarterial nedaplatin and pirarubicin plus intravenous methotrexate and vincristine. Int J Clin Oncol 2006;11:329–331.
   PubMedGoogle Scholar
• Nash P. Alefacept plus methotrexate for psoriatic arthritis. Nat Clin Pract Rheumatol 2006;2:470–471.
   PubMedGoogle Scholar
• Gray OM, McDonnell GV, Forbes RB. A systematic review of oral methotrexate for multiple sclerosis. Mult Scler 2006;12:507–510.
   PubMed Web of Science ®Google Scholar
• McNeish IA, Strickland S, Holden L, Rustin GJ, Foskett M, Seckl MJ, Newlands ES. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol 2002;20:1838–1844.
   PubMed Web of Science ®Google Scholar
• Bannwarth B, Labat L, Moride Y, Schaeverbeke T. Methotrexate in rheumatoid arthritis. Drugs 1994;47:25–50.
   PubMed Web of Science ®Google Scholar
• Alshimmiri MM, Al-Saleh E, Al-Harmi JA, Alsalili MB, Adwani AA, Ibrahim ME. Treatment of ectopic pregnancy with a single intramuscular dose of methotrexate. Arch Gynecol Obstet 2003;268:181–183.
   PubMedGoogle Scholar
• Periti E, Comparetto C, Villanucci A, Coccia ME, Tavella K, Amunni G. The use of intravenous methotrexate in the treatment of ectopic pregnancy. J Chemother 2004;16:211–215.
   PubMed Web of Science ®Google Scholar
• Dalkalitsis N, Stefos T, Kaponis A, Tsanadis G, Paschopoulos M, Dousias V. Reproductive outcome in patients treated by oral methotrexate or laparoscopic salpingiotomy for the management of tubal ectopic pregnancy. Clin Exp Obstet Gynecol 2006;33:90–92.
   PubMedGoogle Scholar
• Warkany J. Teratogenicity of folic acid antagonists. Cancer Bull 1981;33:76–77.
   Google Scholar
• Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation, 5th ed. Baltimore: Williams and Wilkins, 1998. pp 702–706.
   Google Scholar
• Buckley LM, Bullaboy CA, Leichtman L, Marquet M. Multiple congenital anomalies associated with weekly lowdose methotrexate treatment of the mother. Arthritis Rheum 1997;40:971–973.
   PubMed Web of Science ®Google Scholar
• Schleuning M, Clemm C. Chromosomal aberrations in a newborn whose mother received cytotoxic treatment during pregnancy. New Eng J Med 1987;317:1666–1667.
   PubMed Web of Science ®Google Scholar
• Milunsky A, Graef JW, Gaynor MF. Methotrexate-induced congenital malformations. J Peditar 1968;72:790–795.
   PubMed Web of Science ®Google Scholar
• Ostensen M, Hartmann H, Salvensen K. Low dose weekly methotrexate in early pregnancy. A case series and review of the literature. J Rheumatol 2000;27:1872–1875.
   PubMed Web of Science ®Google Scholar
• Rustin GJS, Booth M, Dent J, Salt S, Rustin F, Bagshawe KD. Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours. BMJ 1984;288:103–106.
   PubMed Web of Science ®Google Scholar
• Al-Saleh E, Al-Harmi J, Al-Rashdan I, Al-Shammari M, Nandakumaran M. Maternal-fetal transport kinetics of methotrexate in perfused human placenta: in vitro study. J Mat-Fet Neonat Med 2007;20:411–418.
   PubMed Web of Science ®Google Scholar
• Mertz W. The essential trace elements. Science 1981;213:1332–1338.
   PubMed Web of Science ®Google Scholar
• Peerebom JWC. General aspects of trace elements and health. Sci Total Environ 1985;42:1–27.
   Web of Science ®Google Scholar
• Gibson RS. Assessment of trace element status in humans. Progr Nutr Sci 1989;13:67–111.
   PubMedGoogle Scholar
• Oktem F, Yilmaz HR, Ozguner F, Olgar S, Avata A, Uzare E, Uz E. Mtehotrexate-induced renal oxidative stress in rats: the role of a novel antioxidant caffeic acid phenethyl ester. Toxicol Ind Health 2006;22:241–247.
   PubMed Web of Science ®Google Scholar
• Cetiner M, Sener G, Schirli AO, Eksioglu-Demiralp E, Ercan F, Sirvanci S, Gedik N, Akpulat S, Tecimer T, Yegen BC. Taurine protects against methotrexate-induced toxicity and inhibits leucocyte death. Toxicol Appl Pharmacol 2005;209:39–50.
   PubMed Web of Science ®Google Scholar
• Devrim E, Cetim R, Klicoglu B, Erguder BI, Avci A, Durak I. Methotrexate causes oxidative stress in rat kidney tissues. Ren Fail 2005;27:771–773.
   PubMed Web of Science ®Google Scholar
• Vernie IN, De Vries M, Benckhuijsen C, De Goeij JJ, Zegers C. Selenium levels in blood and plasma and glutathione peroxidase activity in blood of breast cancer patients during adjuvant treatment with cyclophosphamide, methotrexate and 5-fluorouracil. Cancer Lett 1983;18:283–289.
   PubMed Web of Science ®Google Scholar
• Huang CC, Hsu PC, Hung YC, Liao YF, Liu CC, Hour CT, Kao MC, Tsay GJ, Hung HC, Liu GY. Orntihine decarboxylase prevents methotrexate-induced apoptosis by reducing intracellular reactive oxygen species production. Apoptosis 2005;10:895–907.
   PubMed Web of Science ®Google Scholar
• Cetinkaya A, Bulbuloglu E, Kurutas EB, Kantarceken B. N-acetylcysteine ameliorates methotrexate-induced oxidative liver damage in rats. Med Sci Monit 2006;12:274–278.
   Web of Science ®Google Scholar
• Helmy M, Shohayeb M, Helmy MH, el-Bassiouni EA. Antioxidants as adjuvant therapy in rheumatoid disease. A preliminary study. Arzneimittelforschung 2001;51:293–298.
   PubMed Web of Science ®Google Scholar
• Brock S, Jennings HR. Fetal acute encephalomyelitis after a single dose of intrathecal methotrexate. Pharmacotherapy 2004;24:673–676.
   PubMed Web of Science ®Google Scholar
• Valik D, Sterba J, Bajciova V, Demlova R. Severe encephalopathy induced by the first but not the second course of high dose methotrexate mirrored by plasma homocysteine evaluations and preceded by extreme differences in pretreatment plasma folate. Oncology 2005;69:269–272.
   PubMed Web of Science ®Google Scholar
• Khan F, Everard J, Ahmed S, Coleman RE, Aitken M, Hancock BW. Low-risk persietent gestational trophoblastic disease treated with low-dose methotrexate: efficacy, acute and long-term effects. Br J Cancer 2003;89:2197–2101.
   PubMed Web of Science ®Google Scholar
• Troche G, Sacquin P, Achkar A, Korach JM, Laaban JP, Gajdos P. Severe methotrexate poisoning. Presse Med 1991;20:1724–1727.
   PubMed Web of Science ®Google Scholar
• Chatham WW, Morgan SL, Alarcon GS. Renal failure: a risk factor for methotrexate toxicity. Arthritis Rheum 2000;43:1185–1186.
   PubMed Web of Science ®Google Scholar
• Widemann BC, Hetherington ML, Murphy RF, Balis FM, Adamson PC. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity. Cancer 1995;76:521–526.
   PubMed Web of Science ®Google Scholar
• Sieber SM, Adamson RH. Toxicity of antineoplastic agents in man: chromosomal aberrations, antifertility effects, congenital malformations and carcinogenic potential. Adv Cancer Res 1975;22:57–155.
   PubMedGoogle Scholar